AI agents for Pharmaceuticals & Biotech
Research literature grows faster than any team can read, trials recruit slower than they should, and every regulated document trails a validation burden. SIAS deploys agents from the Healthcare and Life Sciences (HCX), Legal (LEG), and GRC groups with the audit trail regulated work demands.
Pharma and biotech work is gated by documents: literature to review, protocols to match patients against, submissions to file, and batch records to defend. The science is the point; the document load around it is what stretches timelines.
Regulated environments cannot adopt AI that cannot show its work. Every SIAS agent output carries its sources, every action is attributable to a specific agent identity, and validation-relevant workflows stay at read-and-report until your quality organization approves anything more.
Agent use cases for pharmaceuticals & biotech
Every use case below maps to named agents in the SIAS catalog (506 agents across 8 domains), grounded in your corpora and governed by the three autonomy tiers: T1 read-and-report, T2 supervised writes, T3 human-gated.
Discovery literature research
Sweeps and summarizes literature with citations so scientists start from a map, not a search box.
Catalog agents: Drug Discovery Literature Research; Medical Research Assistant (HCX)
Autonomy: T1
Clinical trial matching
Matches patients against protocol criteria to accelerate recruitment, as decision support.
Catalog agents: Clinical Trial Matching (HCX)
Autonomy: T1
Regulatory filing support
Drafts filing sections and tracks regulatory change across the markets you file in.
Catalog agents: Regulatory Filing (LEG); Regulatory Change Monitoring (GRC)
Autonomy: T1
Safety-signal triage
Surfaces anomalies in safety and quality data streams for pharmacovigilance review.
Catalog agents: Anomaly Detection; Data Quality (DAT)
Autonomy: T1
GxP compliance evidence
Maps controls, runs checks, and assembles audit evidence continuously across quality systems.
Catalog agents: Compliance Mapping (SOC 2 / ISO 27001 / HIPAA / PCI / FedRAMP); Control Testing; Evidence Collection (GRC)
Autonomy: T1
Clinical documentation
Drafts structured clinical and study documentation for investigator and medical-writer review.
Catalog agents: Clinical Documentation (HCX)
Autonomy: T1
Data integrity and lineage
Tracks lineage and quality across research and manufacturing data so provenance questions have answers.
Catalog agents: Data Quality; Data Lineage (DAT)
Autonomy: T1
IP and patent watch
Monitors patent activity and drafts research memos with cited sources.
Catalog agents: IP and Trademark Watch; Legal Research (LEG)
Autonomy: T1
Manufacturing quality
Watches equipment and quality data for drift; nothing on the platform writes to a control system.
Catalog agents: Predictive Maintenance; Quality Inspection Analysis (MFG)
Autonomy: T1
Medical communications drafting
Drafts outreach and communications against your approved content; publishing stays a human action.
Catalog agents: Patient Communication and Outreach (HCX); Content Creation (MKT)
Autonomy: T2
How a rollout runs
- T1 research and evidence assembly. Literature research, trial matching, and compliance evidence run read-and-report — high value with zero write risk.
- T2 drafting into document systems. Filing sections and controlled documents draft into your document management system under scoped credentials, pending QA approval.
- Validation-relevant workflows stay gated. Anything feeding a submission, a label, or a batch decision remains draft-only behind named approvers.
Questions pharmaceuticals & biotech buyers ask
How does this fit a validated (GxP) environment?
Agents start at read-and-report, where they summarize, match, and assemble evidence without touching validated systems. Every output carries citations and every action is logged and attributable, which is the evidence trail your quality organization needs to assess them. Writes into controlled systems happen only after your validation review, at supervised tiers.
Can agents access our proprietary research data safely?
Corpora stay under your control and are tenancy-isolated per engagement, so one workstream cannot read another. Agents hold scoped, short-lived credentials issued per purpose. Nothing is pooled across clients and nothing trains on your data.
Do agents write regulatory submissions?
They draft sections and track requirements; regulatory affairs owns every submission. The drafting agents are grounded in your prior filings and current regulatory texts, and their outputs cite what they relied on. Filing remains a human decision behind named approvers.
Where do pharma engagements usually start?
Literature research and clinical trial matching, because both are pure read-and-report with immediate, visible value to scientific teams. GxP evidence collection is a common parallel start because audits are perpetual. Both prove the governance model before anything touches a regulated document flow.
Adjacent industries
Healthcare
Governed AI agents for healthcare: prior authorization, clinical documentation, patient intake, denial management, and HEDIS reporting — PHI tenancy-isolated, every action logged.
Manufacturing
Governed AI agents for manufacturing: predictive maintenance, quality inspection analysis, supply-chain exception handling, production scheduling, and HSE compliance — OT read-only by design.
Legal Services
Governed AI agents for law firms and legal departments: contract review, NDA triage, eDiscovery, legal research, obligation tracking, and billing review — privileged corpora tenancy-isolated.
Scope the first agent for your pharmaceuticals & biotech stack
A 30-minute discovery call maps your highest-friction queue to catalog agents and a Tier-1 starting point. Fixed-fee engagements from a $15K Starter Pilot — full pricing is on the enterprise page.
Book a discovery call